In February 2005, Takeda announced its acquisition of San Diego, California, based Syrrx, a company specializing in high-throughput X-ray crystallography, for USD270 million.
I februar 2005 bekendtgjorde Takeda overtagelsen af det San Diego-baserede Syrrx, et selskab specialiseret i high-throughput X-ray crystallography, for 270 mio. USD.